In the intricate world of pharmaceutical development, the selection of high-quality chemical intermediates is paramount. Among these crucial building blocks is 2-Bromo-4-chloro-6-fluoroaniline, identified by its CAS number 195191-47-0. This tri-halogenated aniline derivative is highly sought after by researchers and manufacturers for its unique chemical properties and its pivotal role in synthesizing complex organic molecules, particularly those destined for therapeutic applications. As a leading supplier of fine chemicals from China, understanding the significance and sourcing of such compounds is key to driving innovation in drug discovery.
The structural complexity of 2-Bromo-4-chloro-6-fluoroaniline, featuring bromine, chlorine, and fluorine atoms strategically placed on an aniline ring, provides chemists with exceptional versatility. These halogen substituents offer distinct points of reactivity, enabling selective functionalization through various chemical reactions such as cross-coupling. This makes it an indispensable precursor for creating novel drug candidates that might otherwise be difficult to synthesize. For pharmaceutical research aiming to develop compounds with specific biological activities, such as modulating pain and inflammation pathways, this intermediate is invaluable.
One of the significant applications of 2-Bromo-4-chloro-6-fluoroaniline lies in the development of bradykinin B1 receptor antagonists. These compounds are being investigated for their potential to manage chronic pain and inflammatory conditions. The ability to precisely engineer molecules using this intermediate allows for the fine-tuning of pharmacokinetic and pharmacodynamic properties, which is a critical step in transforming a research compound into a viable therapeutic agent. Furthermore, its structure also lends itself to the exploration of new anticancer agents, where halogenated aromatic compounds have shown promising cytotoxic effects.
For procurement managers and R&D scientists in the pharmaceutical industry, ensuring a stable and reliable supply of high-purity intermediates like 2-Bromo-4-chloro-6-fluoroaniline is non-negotiable. Sourcing from reputable manufacturers in China, such as those specializing in fine chemicals, offers distinct advantages. These include competitive pricing, bulk availability, and often, adherence to stringent quality control standards necessary for pharmaceutical-grade materials. When seeking to buy this compound, it is advisable to work with suppliers who can provide comprehensive product specifications, including purity levels (typically >98%) and reliable supply chain management.
In conclusion, 2-Bromo-4-chloro-6-fluoroaniline (CAS 195191-47-0) is far more than just a chemical compound; it is a gateway to innovative drug development. Its unique structure and reactivity empower chemists to build molecules that address unmet medical needs. For companies looking to secure this essential pharmaceutical intermediate, partnering with a trustworthy manufacturer and supplier in China ensures access to the quality and quantity required to advance critical research and development projects.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.